The Society for Women's Health Research (SWHR)

Springboard Enterprises' 2024 State of Women's Health Report

Stream "Increasing Impact: Leveraging Data to Drive Healthcare Access and Advancement"

2024 Global Access Fellow Spotlight on Magdalene Mallory

2024 Access to Medicines Internship Spotlight on Amanda Bowlin

2024 Global Access Fellow Spotlight on Mackenzie Greene

2024 Access to Medicines Internship Spotlight on Ethan Hsu

2024 Access to Medicines Internship Spotlight on Derek Bassett

Roivant Sciences, Roivant Social Ventures (RSV), and Elutia have partnered to create summer internship opportunities to provide real-world drug development experience to talented PharmD students. The intentions of this program are to expand access to medicines to underserved populations, and to further UNC Eshelman School of Pharmacy's goal of providing future industry leaders with pharmaceutical experience during their PharmD tenure.

Roivant Social Ventures is proud to announce the launch of our inaugural Convergence Forum Fellowship Program in support of CEOs championing healthcare equity through the development of therapeutics and technology. 

"Most of the treatments and cures that pharmaceutical companies focus on are for illnesses that affect white men, rather than women or people of color, said Lindsay Androski, CFA, President and CEO of Roivant Social Ventures and an independent director at Eloxx Pharmaceuticals.

“I do not believe this is because of malice but because people have a human tendency to want to make a difference in areas that have impacted them or their loved ones personally,” Androski told BioSpace. “But one area where I can make an impact today is to expose more talented future leaders to the industry and get them in the front door at the beginning of their careers.”

2023 Global Access Fellow Spotlight on Caroline Eason

2023 Diversity in Pharma Intern Spotlight on Dahye Kim

2023 Diversity in Pharma Intern Spotlight on Diana Locoteta

2023 Diversity in Pharma Intern Spotlight on Hannah Summers

Roivant Sciences and Roivant Social Ventures Launch Inaugural Diversity in Pharma Internships for Talented PharmD Students 

Taught by Lindsay Androski, RSV Founder and CEO, and Scott Singleton, Associate Professor at the UNC Eshelman School of Pharmacy

Reflecting on a Remarkable Year of Progress: A Letter from Roivant Social Ventures President & CEO Lindsay Androski

Roivant Social Ventures Publishes Global Access Scorecard to Guide Impact Investors in Making Equitable Investment Decisions